InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: Traderbx post# 18316

Friday, 04/14/2017 5:54:25 PM

Friday, April 14, 2017 5:54:25 PM

Post# of 108192
"But it also could signal an increasing tolerance for other approaches. And this is the biggest implication for those looking for diamonds in the rough with the stock market. Lots of small up-and-comers are exploring cell-based immunotherapy in various forms. To name just a few:

Company Lead product
Inovio (NYSEMKT:INO) SynCon vaccines
Advaxis, Inc (NASDAQ:ADXS) Listeria-based vaccines
Aduro Biotech (NASDAQ:ADRO) Listeria-based vaccines
Northwest Biotherapeutics (NASDAQ:NWBO) Dendritic cell vaccine
Sorrento Therapeutics (NASDAQ:SRNE) Solid tumor CAR-T cells
OncoSec Medical (NASDAQ:ONCS) Interleukin-12 DNA pulse
Oncolytics (OTCQX:ONCYF) Reolysin,tumor-killingvirus"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News